General shareholders' meetings

  • 2014 Extraordinary

    Relevant fact convening the extraordinary general shareholders' meeting (PDF)

    Right of attendance and representation (PDF)


    * The following documents are only available on the Spanish site.

    Presentation of the extraordinary general shareholders meeting
    Proposals of the board of directors
    1 - Merger project
    2.1 - Report by Natraceutial's directors from 23 07 2014
    2.2 - Report by Laboratorio Reig Jofre's directors from 23 07 2014
    3 - Independent valuation report
    4.1.1 - Natraceutical's 2011 annual accounts
    4.1.2 - Natraceutical's 2012 annual accounts
    4.1.3 - Natraceutical's 2013 annual accounts
    4.2.1 - Laboratorio Reig Jofre 2011 annual accounts
    4.2.2 - Laboratorio Reig Jofre 2012 annual accounts
    4.2.3 - Laboratorio Reig Jofre 2013 annual accounts
    5.1 - Natraceutical's merger balance on 31 12 2013
    5.2 - Laboratorio Reig Jofre's merger balance on 30 04 2013
    6.1 - Natraceutical's bylaws
    6.2 - Laboratorio Reig Jofre's bylaws
    7 - Bylaws of the resulting company
    8 - Directors of Natraceutical, of Laboratorio Reig Jofre and of the resulting company
    Presentation General Extraordinary Shareholders’ Meeting

    Relevant fact with the resolutions of the extraordinary general shareholders meeting (PDF)

  • 2011

    * The information of the general shareholders’ meeting prior to 2012 is only available on the Spanish site.

  • 2010

    * The information of the general shareholders’ meeting prior to 2012 is only available on the Spanish site.

  • 2009

    * The information of the general shareholders’ meeting prior to 2012 is only available on the Spanish site.

This site uses only technical third party cookies to provide better service, when browsing this website you agree to its use. See ourlegal advice. Agree

DMC Firewall is developed by Dean Marshall Consultancy Ltd